11.1 Information on toxicological effects
Acute toxicity
Acute toxicity estimate Oral - 100.1 mg/kg (Expert judgement)
Remarks: Classified according to Regulation (EU) 1272/2008, Annex VI (Table 3.1/3.2)
Acute toxicity estimate Inhalation - 4 h - 0.6 mg/l - dust/mist (Expert judgement)
Remarks: Classified according to Regulation (EU) 1272/2008, Annex VI (Table 3.1/3.2)
Dermal: No data available
Skin corrosion/irritation
Classified based on available data. For more details, see section 2
Serious eye damage/eye irritation
Classified based on available data. For more details, see section 2
Respiratory or skin sensitization
Classified based on available data. For more details, see section 2
Germ cell mutagenicity
Classified based on available data. For more details, see section 2
Carcinogenicity
This product is or contains a component that is not classifiable as to its carcinogen- icity based on its IARC, ACGIH, NTP, or EPA classification.
Reproductive toxicity
Classified based on available data. For more details, see section 2
Specific target organ toxicity - single exposure
Classified based on available data. For more details, see section 2
Specific target organ toxicity - repeated exposure
Classified based on available data. For more details, see section 2
Aspiration hazard
Classified based on available data. For more details, see section 2
11.2 Additional Information
burning, dry nose, dry mouth, Muscle cramps/spasms., Nausea, Vomiting, Diar- rhoea, Shock., May cause irritation of the:, Gastrointestinal tract, death
To the best of our knowledge, the chemical, physical, and toxicological properties have not been thoroughly investigated.
The following applies to arsenic and its compounds in general: they take effect as capillary and enzyme toxins. Symptoms of arsenic poisoning: acute: after inhala- tion, mucosal irritations with coughing, dyspnoea, pain in the thorax. Perforations within the respiratory tract are possible. After oral uptake, gastrointestinal disor- ders with vomiting, diarrhoea, and spasms, CNS disorders with headache, confu- sion, shaking fits and disturbed consciousness, cardiovascular disorders all the way to circulatory collapse. Chronic: exanthema, dermal lesions in the form of hyper- keratosis and hypermelanosis, loss of hair, conjunctivitis and polyneuropathy, im- paired hepatic function, and renal damage. After accumulation in the liver, kidneys, and skin, arsenic is eliminated from the organism only slowly. Experience has shown arsenic compounds to be carcinogenic in man.
The following applies to azo dyes in general: azo dyes containing a carcinogenic ar- yl amine component are suspected of possessing a carcinogenic potential. It is therefore recommended that the substance be handled as if it possessed the prop- erties of the basic amine.